543 related articles for article (PubMed ID: 18992679)
1. Soluble and membranous vascular endothelial growth factor receptor-1 in pregnancies complicated by pre-eclampsia.
Tripathi R; Rath G; Jain A; Salhan S
Ann Anat; 2008 Nov; 190(5):477-89. PubMed ID: 18992679
[TBL] [Abstract][Full Text] [Related]
2. Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia.
Chaiworapongsa T; Romero R; Kim YM; Kim GJ; Kim MR; Espinoza J; Bujold E; Gonçalves L; Gomez R; Edwin S; Mazor M
J Matern Fetal Neonatal Med; 2005 Jan; 17(1):3-18. PubMed ID: 15804781
[TBL] [Abstract][Full Text] [Related]
3. Soluble and membranous vascular endothelial growth factor receptor-2 in pregnancies complicated by pre-eclampsia.
Tripathi R; Rath G; Ralhan R; Saxena S; Salhan S
Yonsei Med J; 2009 Oct; 50(5):656-66. PubMed ID: 19881969
[TBL] [Abstract][Full Text] [Related]
4. [The relativity of vascular endothelium growth factor receptor-1 and preeclampsia].
Zou CL; Liu XH; Yue BM; Fu JH; He GL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Sep; 37(5):765-8. PubMed ID: 17037747
[TBL] [Abstract][Full Text] [Related]
5. VEGF and its soluble receptor VEGFR-2 in hypertensive disorders during pregnancy: the Indian scenario.
Rath G; Tripathi R
J Hum Hypertens; 2012 Mar; 26(3):196-204. PubMed ID: 21412269
[TBL] [Abstract][Full Text] [Related]
6. Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award.
Chaiworapongsa T; Romero R; Espinoza J; Bujold E; Mee Kim Y; Gonçalves LF; Gomez R; Edwin S
Am J Obstet Gynecol; 2004 Jun; 190(6):1541-7; discussion 1547-50. PubMed ID: 15284729
[TBL] [Abstract][Full Text] [Related]
7. Soluble VEGFR-1 in pathophysiology of pregnancies complicated by hypertensive disorders: the Indian scenario.
Tripathi R; Ralhan R; Saxena S; Salhan S; Rath G
J Hum Hypertens; 2013 Feb; 27(2):107-14. PubMed ID: 22357551
[TBL] [Abstract][Full Text] [Related]
8. Maternal serum-soluble vascular endothelial growth factor receptor-1 in early pregnancy ending in preeclampsia or intrauterine growth retardation.
Wathén KA; Tuutti E; Stenman UH; Alfthan H; Halmesmäki E; Finne P; Ylikorkala O; Vuorela P
J Clin Endocrinol Metab; 2006 Jan; 91(1):180-4. PubMed ID: 16263826
[TBL] [Abstract][Full Text] [Related]
9. Extra-placental expression of vascular endothelial growth factor receptor-1, (Flt-1) and soluble Flt-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women.
Rajakumar A; Michael HM; Rajakumar PA; Shibata E; Hubel CA; Karumanchi SA; Thadhani R; Wolf M; Harger G; Markovic N
Placenta; 2005 Aug; 26(7):563-73. PubMed ID: 15993706
[TBL] [Abstract][Full Text] [Related]
10. Smoking and sVEGFR-1: circulating maternal concentrations and placental expression.
Kämäräinen M; Soini T; Wathén KA; Leinonen E; Stenman UH; Vuorela P
Mol Cell Endocrinol; 2009 Feb; 299(2):261-5. PubMed ID: 19103251
[TBL] [Abstract][Full Text] [Related]
11. Maternal serum endostatin at gestational weeks 16-20 is elevated in subsequent pre-eclampsia but not in intrauterine growth retardation.
Wathén KA; Ylikorkala O; Andersson S; Alfthan H; Stenman UH; Vuorela P
Acta Obstet Gynecol Scand; 2009; 88(5):593-8. PubMed ID: 19308751
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia is responsible for soluble vascular endothelial growth factor receptor-1 (VEGFR-1) but not for soluble endoglin induction in villous trophoblast.
Munaut C; Lorquet S; Pequeux C; Blacher S; Berndt S; Frankenne F; Foidart JM
Hum Reprod; 2008 Jun; 23(6):1407-15. PubMed ID: 18413304
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor-alpha in the placenta is not elevated in pre-eclamptic patients despite its elevation in peripheral blood.
Hayashi M; Ueda Y; Yamaguchi T; Sohma R; Shibazaki M; Ohkura T; Inaba N
Am J Reprod Immunol; 2005 Mar; 53(3):113-9. PubMed ID: 15727564
[TBL] [Abstract][Full Text] [Related]
14. [Expression of various subtypes of human leukocyte antigen-G in placenta of patients complicated with severe pre-eclampsia].
He YD; Li YL; Chen Q
Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):29-32. PubMed ID: 22455690
[TBL] [Abstract][Full Text] [Related]
15. Serum endostatin and vascular endothelial growth factor levels in patients with pre-eclampsia.
Mahmound RA; Abdel-Raouf M
East Mediterr Health J; 2006; 12(1-2):178-87. PubMed ID: 17037236
[TBL] [Abstract][Full Text] [Related]
16. Endothelin system in normal and hypertensive pregnancy.
Slowinski T; Neumayer HH; Stolze T; Gossing G; Halle H; Hocher B
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():446S-449S. PubMed ID: 12193142
[TBL] [Abstract][Full Text] [Related]
17. Serum markers of macrophage activation in pre-eclampsia: no predictive value of soluble CD163 and neopterin.
Kronborg CS; Knudsen UB; Moestrup SK; Allen J; Vittinghus E; Møller HJ
Acta Obstet Gynecol Scand; 2007; 86(9):1041-6. PubMed ID: 17712642
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of physiological alterations of the placenta through analysis of cell-free messenger ribonucleic acid concentrations of angiogenic factors.
Purwosunu Y; Sekizawa A; Farina A; Wibowo N; Koide K; Okazaki S; Nakamura M; Okai T
Am J Obstet Gynecol; 2008 Jan; 198(1):124.e1-7. PubMed ID: 18166325
[TBL] [Abstract][Full Text] [Related]
19. sCD40 ligand determined in maternal and umbilical cord blood in pregnancies complicated by pre-eclampsia with and without intrauterine growth retardation.
Laskowska M; Laskowska K; Leszczyńska-Gorzelak B; Oleszczuk J
Gynecol Obstet Invest; 2007; 64(1):8-13. PubMed ID: 17199090
[TBL] [Abstract][Full Text] [Related]
20. [Predictive value of soluble vascular endothelial growth factor receptor 1 for preeclampsia in second-trimester].
Chen Q; Zhao Y; Zou L; Wang ZH
Zhonghua Fu Chan Ke Za Zhi; 2007 Mar; 42(3):161-4. PubMed ID: 17537299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
